First Time Loading...

Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX

Watchlist Manager
Ortho Clinical Diagnostics Holdings PLC Logo
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Watchlist
Price: 17.63 USD 0.46% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

OCDX price has not been updated for more than 8 months. This may indicate that the stock has been delisted.

Ortho Clinical Diagnostics Holdings Plc provides vitro diagnostics services. [ Read More ]

There is not enough data to reliably calculate the intrinsic value of OCDX.

Key Points:
OCDX Intrinsic Value
Base Case
Not Available
Base Case Scenario

Fundamental Analysis

How can I assist you today?

Provide an overview
of Ortho Clinical Diagnostics Holdings PLC's business.

What risks and challenges
does Ortho Clinical Diagnostics Holdings PLC face in the near future?

Summarize the latest earnings report
of Ortho Clinical Diagnostics Holdings PLC.

Provide P/E
for Ortho Clinical Diagnostics Holdings PLC and its competitors.

Financials

Balance Sheet Decomposition
Ortho Clinical Diagnostics Holdings PLC

Current Assets 989.6m
Cash & Short-Term Investments 281.1m
Receivables 293.2m
Other Current Assets 415.3m
Non-Current Assets 2.3B
PP&E 784.2m
Intangibles 840.7m
Other Non-Current Assets 701.9m
Current Liabilities 522.7m
Accounts Payable 169.5m
Accrued Liabilities 239.7m
Other Current Liabilities 113.5m
Non-Current Liabilities 2.4B
Long-Term Debt 2.2B
Other Non-Current Liabilities 173.3m
Efficiency

Earnings Waterfall
Ortho Clinical Diagnostics Holdings PLC

Revenue
2B USD
Cost of Revenue
-1B USD
Gross Profit
1B USD
Operating Expenses
-864.5m USD
Operating Income
163.5m USD
Other Expenses
-163.9m USD
Net Income
-400k USD

Free Cash Flow Analysis
Ortho Clinical Diagnostics Holdings PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

OCDX Profitability Score
Profitability Due Diligence

Ortho Clinical Diagnostics Holdings PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive Free Cash Flow
Positive 1-Year Revenue Growth
49/100
Profitability
Score

Ortho Clinical Diagnostics Holdings PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

OCDX Solvency Score
Solvency Due Diligence

Ortho Clinical Diagnostics Holdings PLC's solvency score is 23/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Low Altman Z-Score
23/100
Solvency
Score

Ortho Clinical Diagnostics Holdings PLC's solvency score is 23/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OCDX Price Targets Summary
Ortho Clinical Diagnostics Holdings PLC

There are no price targets for OCDX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

OCDX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

OCDX Price
Ortho Clinical Diagnostics Holdings PLC

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-2%
5Y 5Y
+10%
10Y 10Y
+10%
Annual Price Range
17.63
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -28%
Shares Statistics
Market Capitalization 4.2B USD
Shares Outstanding 237 735 008
Percentage of Shares Shorted 5.91%

OCDX Return Decomposition
Main factors of price return

What is price return decomposition?

OCDX News

Last Important Events
Ortho Clinical Diagnostics Holdings PLC

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Ortho Clinical Diagnostics Holdings PLC

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Ortho Clinical Diagnostics Holdings PLC Logo
Ortho Clinical Diagnostics Holdings PLC

Country

United States of America

Industry

Health Care

Market Cap

4.2B USD

Dividend Yield

0%

Description

Ortho Clinical Diagnostics Holdings Plc provides vitro diagnostics services. The company is headquartered in Raritan, New Jersey and currently employs 4,800 full-time employees. The company went IPO on 2021-01-28. The firm provides laboratory testing and blood-typing solutions to the clinical laboratory and transfusion medicine communities. The firm provides customized solutions for clinical outcomes, lab performance and staffing challenges. The firm operates through two lines of business such as Clinical Laboratories and Transfusion Medicine. Its Clinical Laboratories business focuses on clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across therapeutic areas. The Transfusion Medicine business is focused on immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions. Its Donor Screening business is focused on instruments and tests used for blood and plasma screening for infectious diseases for customers, which include some of the donor testing institutions.

Contact

NEW JERSEY
Raritan
1001 Route 202
+19082188000.0
https://www.orthoclinicaldiagnostics.com/

IPO

2021-01-28

Employees

4 800

Officers

Chairman & CEO
Mr. Christopher Michael Smith
Chief Financial Officer
Mr. Joseph M. Busky CPA
Exec. VP, Gen. Counsel & Sec.
Mr. Michael A. Schlesinger
Exec. VP of Commercial Excellence & Strategy
Mr. Michael S. Iskra
Chief Innovation Officer
Dr. Chockalingam Palaniappan Ph.D.
Chief Information Officer
Ms. Ariane Schiereck
Show More
Head of Quality, Regulatory, Compliance, Clinical, Medical & Scientific Affairs
Mr. Marwan Fathallah
Head of People & Culture
Mr. Gary Passman
Head of Global Commercial Enablement
Karen Taylor
Head of Americas
Mr. Warren Stone
Show Less

See Also

Discover More